CN102614431A - 治疗痛风及骨病的药物 - Google Patents
治疗痛风及骨病的药物 Download PDFInfo
- Publication number
- CN102614431A CN102614431A CN2012101188112A CN201210118811A CN102614431A CN 102614431 A CN102614431 A CN 102614431A CN 2012101188112 A CN2012101188112 A CN 2012101188112A CN 201210118811 A CN201210118811 A CN 201210118811A CN 102614431 A CN102614431 A CN 102614431A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- radix
- gout
- bone disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 208000020084 Bone disease Diseases 0.000 title abstract 3
- 241000255791 Bombyx Species 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 4
- 241001057584 Myrrha Species 0.000 claims description 4
- 241001604597 Pyrestini Species 0.000 claims description 4
- 241000131808 Scolopendra Species 0.000 claims description 4
- 241000522620 Scorpio Species 0.000 claims description 4
- 241000726094 Aristolochia Species 0.000 claims description 2
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 2
- 241000612166 Lysimachia Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 241000405217 Viola <butterfly> Species 0.000 claims description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 241000227129 Aconitum Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000282817 Bovidae Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000003385 Diospyros ebenum Nutrition 0.000 abstract 1
- 241000792913 Ebenaceae Species 0.000 abstract 1
- 241001125671 Eretmochelys imbricata Species 0.000 abstract 1
- 244000223060 Erythrina herbacea Species 0.000 abstract 1
- 235000005280 Erythrina herbacea Nutrition 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000219991 Lythraceae Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 239000003088 amphibian venom Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 abstract 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 abstract 1
- 238000010926 purge Methods 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000007850 degeneration Effects 0.000 description 8
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 7
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 201000008482 osteoarthritis Diseases 0.000 description 7
- 229940116269 uric acid Drugs 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 208000008035 Back Pain Diseases 0.000 description 6
- 208000008930 Low Back Pain Diseases 0.000 description 6
- 230000036285 pathological change Effects 0.000 description 6
- 231100000915 pathological change Toxicity 0.000 description 6
- 206010005963 Bone formation increased Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 208000036319 cervical spondylosis Diseases 0.000 description 4
- 230000003412 degenerative effect Effects 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- 210000000323 shoulder joint Anatomy 0.000 description 4
- 208000005801 spondylosis Diseases 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 208000007875 Femur Head Necrosis Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000001872 metatarsal bone Anatomy 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- 239000009490 scorpio Substances 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 201000004595 synovitis Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002385 vertebral artery Anatomy 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010056377 Bone tuberculosis Diseases 0.000 description 1
- 206010008334 Cervicobrachial syndrome Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 208000002658 Intra-Articular Fractures Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 208000018359 Systemic autoimmune disease Diseases 0.000 description 1
- 206010043949 Tongue discolouration Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000004221 bone function Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 201000010930 hyperostosis Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000003131 sacroiliac joint Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗痛风及骨病的药物,是由重量份为30份苦参,15份山栀,紫20份花地丁,10份生南星,15份黄芩,15份当归,15份没药,10份川乌,10份草乌,20份海桐皮,15份土茯苓,15份天仙藤,6份僵蚕10份,冰片,5份全蝎,5份蜈蚣,3份蟾酥,6份青矾,6份白矾,30份金钱草,6份羚羊角,10份甲珠,15份玳瑁和20份乌梅组成;本发明主治泻火解毒,利湿通络,适用于治疗痛风及骨病患者。
Description
技术领域
本发明涉及一种治疗痛风及骨病的药物。
背景技术
痛风又称“高尿酸血症”,嘌呤代谢障碍,属于关节炎一种。痛风是人体内嘌呤的物质的新陈代谢发生紊乱,尿酸的合成增加或排出减少,造成高尿酸血症,血尿酸浓度过高时,尿酸以钠盐的形式沉积在关节、软骨和肾脏中,引起组织异物炎性反应,即痛风。
骨病一般包括风湿性关节炎、类风湿性关节炎、退行性关节炎、强直性脊柱炎、颈椎病、腰椎病、肩周炎、骨质增生、股骨头坏死、产后风等。
风湿性关节炎是一种常见的急性或慢性结缔组织炎症。可反复发作并累及心脏。临床一以关节和肌肉游走性酸楚、重著、疼痛为特征.属变态反应性疾病.是风湿热的主要表现之一,多以急性发热及关节疼痛起病。
类风湿性关节炎是一种以关节滑膜炎为特征的慢性全身性自身免疫性疾病。滑膜炎持久反复发作,可导致关节内软骨和骨的破坏,关节功能障碍,甚至残废。血管炎病变累及全身各个器官,故本病又称为类风湿病。
退行性关节炎又称肥大性关节炎,是指一些老年人常常会有腰痛、腿痛、关节痛。由于它多见于老年人,因而也称作老年性关节炎。老年性退化,是引起退行性关节炎的主要原因。中老年后,一切组织器官都会发生退行性变化;骨和关节组织也不例外,退行性变化,尤其好发于承重的关节和多活动的关节。过度的负重或过度的使用某些关节,可促进退行性变化的发生。此外,如关节内骨折、糖尿病、长期不恰当地使用肾上腺皮质激素等因素,均可促进退行性变化的形成和加速已存在的退行性变化的发展。
强直性脊柱炎属风湿病范畴,血清阴性脊柱关节病的一种。该病因尚不明确,以脊柱为主要病变的慢性病,累及骶髂关节,引起脊柱强直和纤维化,造成不同程度眼、肺、肌肉、骨骼病变,属自身免疫性疾病。
颈椎病又称颈椎综合征,是颈椎骨关节炎、增生性颈椎炎、颈神经根综合征、颈椎间盘脱出症的总称,是一种以退行性病理改变为基础的疾患。主要由于颈椎长期劳损、骨质增生,或椎间盘脱出、韧带增厚,致使颈椎脊髓、神经根或椎动脉受压,导致一系列功能障碍的临床综合征。表现为颈椎间盘退变本身及其继发性的一系列病理改变,如椎节失稳、松动;髓核突出或脱出;骨刺形成;韧带肥厚和继发的椎管狭窄等,刺激或压迫了邻近的神经根、脊髓、椎动脉及颈部交感神经等组织,并引起各种各样症状和体征的综合征。
医学上所讲的腰椎病,涵盖了“腰椎间盘突出、腰椎骨质增生、腰肌劳损、腰扭伤、腰椎退行性病变、风湿或类风湿性腰痛、腰椎结核、风寒湿性腰痛、瘀血性腰痛、湿热性腰痛、肾虚性腰痛、颈椎病”等疾患。
肩周炎是以肩关节疼痛和活动不便为主要症状的常见病症。本病的好发年龄在50岁左右,女性发病率略高于男性,多见于体力劳动者。如得不到有效的治疗,有可能严重影响肩关节的功能活动。据临床观察,医院常用药合盛堂宗予以治疗,本病早期肩关节呈阵发性疼痛,常因天气变化及劳累而诱发,以后逐渐发展为持续性疼痛,并逐渐加重,昼轻夜重,肩关节向各个方向的主动和被动活动均受限。肩部受到牵拉时,可引起剧烈疼痛。肩关节可有广泛压痛,并向颈部及肘部放射,还可出现不同程度的三角肌的萎缩。
骨质增生症又称为增生性骨关节炎、骨性关节炎、退变性关节病、老年性关节炎、肥大性关节炎,是由于构成关节的软骨、椎间盘、韧带等软组织变性、退化,关节边缘形成骨刺,滑膜肥厚等变化,而出现骨破坏,引起继发性的骨质增生,导致关节变形,当受到异常载荷时,引起关节疼痛,活动受限等症状的一种疾病。骨质增生分原发性和继发性两种。
股骨头坏死,又称股骨头缺血性坏死,为常见的骨关节病之一。大多因风湿病、血液病、潜水病、烧伤等疾患引起,先破坏邻近关节面组织的血液供应,进而造成坏死。其主要症状,从间断性疼痛逐渐发展到持续性疼痛,再由疼痛引发肌肉痉挛、关节活动受到限制,最后造成严重致残而跛行。激素药亦会导致本病的发生。中医认为疾病发生原因为外因和内因,且内因外因相互作用,使人体阴阳失去平衡,气血的失恒而生疾,亦称″髀枢痹″、″骨痹″、″骨萎″。
发明内容
本发明的目的是提供一种治疗痛风及骨病的药物。
本发明是由下述重量份的组分组成:
苦参30份,山栀15份,紫花地丁20份,生南星10份,黄芩15份,当归15份,没药15份,川乌10份,草乌10份,海桐皮20份,土茯苓15份,天仙藤15份,僵蚕6份,冰片10份,全蝎5份,蜈蚣5份,蟾酥3份,青矾6份,白矾6份,金钱草30份,羚羊角6份,甲珠10份,玳瑁15份,乌梅20份。
本发明主治泻火解毒,利湿通络。
本发明以苦参、山栀、黄芩、紫花地丁和生南星清热解毒燥湿,以当归、没药、川乌和草乌行气活血定痛,以海桐皮、土茯苓、天仙藤、僵蚕、全蝎、冰片、蜈蚣和蟾酥通络除风湿除痹,以青矾、白矾和金钱草利便燥湿解毒,以羚羊角、甲珠和玳瑁固本扶正,佐以乌梅以缓其急。
本发明的有益效果:
本发明主治泻火解毒,利湿通络,适用于治疗痛风及骨病患者。
具体实施方式
本实施例是由下述重量份的组分组成:
苦参30g,山栀15g,紫花地丁20g,生南星10g,黄芩15g,当归15g,没药15g,川乌10g,草乌10g,海桐皮20g,土茯苓15g,天仙藤15g,僵蚕6g,冰片10g,全蝎5g,蜈蚣5g,蟾酥3g,青矾6g,白矾6g,金钱草30g,羚羊角6g,甲珠10g,玳瑁15g,乌梅20g。按照上述配方制成450~600ml的汤剂,每日3次,每次服150~200ml。
治疗痛风案例:刘某某,男,45岁,2011年1月11日初诊;患者2001年第一次发病,开始尽在右足关节处红肿热痛,以后逐渐累及右踝关节和左膝关节,且经常反复发作,发作时剧痛难忍,红肿如脱,全身汗如水洗。尤以足关节为甚,日轻夜重,甚至未触即痛增,连声音也有所恶。局部注射吗啡封闭,疼痛也不能缓解。经医院检查,血尿酸:6.21mg%,诊为痛风病,但骨质无异常改变。经服秋水仙碱止痛效果显著,但头晕恶心等副作用反应也大。以后发病症状逐渐加重,发作时间逐渐增长,间隔时间逐渐缩短,仅2010年就发作了5次之多。2010年12月中旬再次急性发作,经西医查:血尿酸:7.35mg%,血沉40mm/h,X线拍片所见:右足第1跖骨远端骨质蚕食样缺损,并发生骨质增生,趾跖关节轻度狭窄。确诊为痛风病。当时因患者不能接受秋水仙碱和可的松治疗,经服磺胺治疗未效,改为中医治疗。就诊时:患者痛苦病容,由人搀扶架双拐而来,两下肢关节疼痛,右足大趾和右踝关节及左膝关节红肿热痛,小便黄赤,苔黄黑厚而湿润,脉细数。
1月18日二诊:服用本药后,下肢肿痛减轻,黄黑苔见退,已能弃拐行走,但行动还不方便。继续服用。
1月28日三诊:痛风症状基本消失,舌黄黑苔已退,行走自如。以后病人病情稳定,继续服用。
3月1日经查血沉4mmm/h,已恢复正常。5月7日检查血尿酸:6.9mg%,也有所降低。以后病情一直稳定,继续服用,观察。
9月16日复查血尿酸:4.55mg%,已基本正常,行动如常人。仍服用药物巩固治疗。
11月12日X线拍片所见:右足第1跖骨远端痛风样病理改变10个月,与前2次片比较其病明显好转。病变原缺损周围骨质增生较著。痛风病基本痊愈。
治疗类风湿关节炎案例:
赵某,女,58岁,农民,患类风湿关节炎3年余,在医院服用激素等治疗后,关节肿痛有所减缓。但两手腕和指关节肿痛不消,膝、踝、髋关节僵硬伴沉感,生活不能自理。由于长期使用激素,出现库欣综合症,血沉76mm/h,RF(一)。服用本发明药物3月余,关节肿痛已平,激素也全部撤销,复查血沉降至12mm/h,基本治愈。
Claims (1)
1.一种治疗痛风及骨病的药物,是由下述重量份的组分组成:
苦参30份,山栀15份,紫花地丁20份,生南星10份,黄芩15份,当归15份,没药15份,川乌10份,草乌10份,海桐皮20份,土茯苓15份,天仙藤15份,僵蚕6份,冰片10份,全蝎5份,蜈蚣5份,蟾酥3份,青矾6份,白矾6份,金钱草30份,羚羊角6份,甲珠10份,玳瑁15份,乌梅20份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210118811 CN102614431B (zh) | 2012-04-21 | 2012-04-21 | 治疗痛风及骨病的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210118811 CN102614431B (zh) | 2012-04-21 | 2012-04-21 | 治疗痛风及骨病的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102614431A true CN102614431A (zh) | 2012-08-01 |
CN102614431B CN102614431B (zh) | 2013-10-23 |
Family
ID=46554879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210118811 Active CN102614431B (zh) | 2012-04-21 | 2012-04-21 | 治疗痛风及骨病的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102614431B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211976A (zh) * | 2013-05-03 | 2013-07-24 | 蔡光正 | 一种治疗痛风的外用中药制剂 |
CN105456537A (zh) * | 2016-01-27 | 2016-04-06 | 李纪美 | 一种治疗痛风性关节炎的外敷药物 |
CN106039113A (zh) * | 2016-07-17 | 2016-10-26 | 徐琛 | 一种用于治疗痛风的中药组方 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682990A (zh) * | 2005-02-22 | 2005-10-19 | 刘敏 | 一种治疗风湿类风湿疾病的药物制剂 |
CN1745801A (zh) * | 2004-09-10 | 2006-03-15 | 崔高远 | 骨刺肿痛消膏 |
CN101049437A (zh) * | 2007-05-11 | 2007-10-10 | 张燕 | 一种外用治疗寒湿痹痛的膏剂 |
CN101337059A (zh) * | 2007-07-06 | 2009-01-07 | 贾清学 | 一种治疗骨质增生的膏药及其制备方法 |
CN101569739A (zh) * | 2009-06-19 | 2009-11-04 | 宿连湘 | 一种治疗胆囊炎的中药组合物及其制备方法 |
CN101791367A (zh) * | 2010-04-21 | 2010-08-04 | 李建奎 | 一种筋骨活血止痛中药贴膏 |
CN102178807A (zh) * | 2011-04-10 | 2011-09-14 | 孙洪友 | 一种治疗跌打损伤、颈腰腿疼痛、类风湿关节炎的膏药 |
-
2012
- 2012-04-21 CN CN 201210118811 patent/CN102614431B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1745801A (zh) * | 2004-09-10 | 2006-03-15 | 崔高远 | 骨刺肿痛消膏 |
CN1682990A (zh) * | 2005-02-22 | 2005-10-19 | 刘敏 | 一种治疗风湿类风湿疾病的药物制剂 |
CN101049437A (zh) * | 2007-05-11 | 2007-10-10 | 张燕 | 一种外用治疗寒湿痹痛的膏剂 |
CN101337059A (zh) * | 2007-07-06 | 2009-01-07 | 贾清学 | 一种治疗骨质增生的膏药及其制备方法 |
CN101569739A (zh) * | 2009-06-19 | 2009-11-04 | 宿连湘 | 一种治疗胆囊炎的中药组合物及其制备方法 |
CN101791367A (zh) * | 2010-04-21 | 2010-08-04 | 李建奎 | 一种筋骨活血止痛中药贴膏 |
CN102178807A (zh) * | 2011-04-10 | 2011-09-14 | 孙洪友 | 一种治疗跌打损伤、颈腰腿疼痛、类风湿关节炎的膏药 |
Non-Patent Citations (2)
Title |
---|
肖萍: "类风湿性关节炎的中药治疗", 《中西医结合与祖国医学》, vol. 14, 31 December 2010 (2010-12-31), pages 100 - 101 * |
鲁生明: "中医治疗类风湿性关节炎的思路", 《蒙古中医药》, no. 11, 30 November 2011 (2011-11-30), pages 74 - 104 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211976A (zh) * | 2013-05-03 | 2013-07-24 | 蔡光正 | 一种治疗痛风的外用中药制剂 |
CN105456537A (zh) * | 2016-01-27 | 2016-04-06 | 李纪美 | 一种治疗痛风性关节炎的外敷药物 |
CN106039113A (zh) * | 2016-07-17 | 2016-10-26 | 徐琛 | 一种用于治疗痛风的中药组方 |
Also Published As
Publication number | Publication date |
---|---|
CN102614431B (zh) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1161147C (zh) | 一种治疗骨关节疾病的口服中药 | |
CN101297946B (zh) | 一种活血化瘀、祛风通络的膏药及其生产方法 | |
CN1118285C (zh) | 一种治疗风寒湿痹证的膏药 | |
CN1706441A (zh) | 治疗关节疼痛的膏药 | |
CN102429956B (zh) | 外用洗药及其使用方法 | |
CN102091289B (zh) | 一种治疗急慢性软组织损伤的中药制剂 | |
CN102106988B (zh) | 一种具有祛风寒湿、活血化瘀、行气止痛的中药制剂 | |
CN100496544C (zh) | 一种治疗疼痛的中药制剂及其制备方法和用途 | |
CN102614431B (zh) | 治疗痛风及骨病的药物 | |
CN102266542B (zh) | 用于治疗骨质增生的药膏贴及其制备方法 | |
CN1235630C (zh) | 一种治疗骨关节疾病的中药膏剂及制备方法 | |
CN103720851A (zh) | 一种治疗骨质增生的中药汤剂 | |
CN101347606B (zh) | 一种治疗风湿骨病的中药膏及其制备方法 | |
CN101953905A (zh) | 治疗颈/腰间盘突出、骨质增生、乳腺增生的微粉药及制备方法 | |
CN101444581A (zh) | 一种外用治疗关节疼痛的除痛膏药 | |
CN107551229A (zh) | 一种药物组合物及其制备方法和用途 | |
CN102600251B (zh) | 一种治疗类风湿关节炎的中药制剂 | |
CN102552843B (zh) | 一种治疗骨关节病的药物组合物 | |
CN103656592A (zh) | 一种治疗颈椎病的中药糊剂及其制备方法 | |
CN104623476A (zh) | 一种治疗骨质增生的中药组合物 | |
CN104547088A (zh) | 一种治疗椎间盘突出症、骨关节炎的药物及其制备方法 | |
CN100349608C (zh) | 用于治疗各种关节病症的丸药及其制备方法 | |
CN104161956B (zh) | 外用痛风关节膏 | |
CN109010494A (zh) | 一种用于治疗类风湿关节炎的中药及其制备方法 | |
CN108619448A (zh) | 一种治疗骨质增生症的膏药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210204 Address after: Room 608, unit 3, building 2, Carnival community, Luyuan District, Changchun City, Jilin Province Patentee after: Han Hexu Patentee after: Yi Gangqiao Address before: Room 608, unit 3, building 2, Carnival community, Luyuan District, Changchun City, Jilin Province Patentee before: Han Hexu |
|
TR01 | Transfer of patent right |